ZNF469 and vascular disorder: We anticipate that our current and future work will help to establish variants in ZNF469 as ACGM pathogenic mutations, which will lead to earlier and more definitive clinical action in patients with these mutations who manifest vasculopathy, potentially mitigating the associated risks of morbidity and mortality.